MedinCell S.A. (EPA:MEDCL)
20.34
-0.46 (-2.21%)
Mar 13, 2026, 5:35 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €730.29 million as of March 13, 2026. Its market cap has increased by 53.00% in one year.
Market Cap
730.29M
Enterprise Value
750.38M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€20.34
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 730.29M, an increase of 399.84%. That is a compound annual growth rate of 24.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 730.29M | -12.46% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.40B |
| Inventiva | 1.02B |
| DBV Technologies | 982.17M |
| Valneva SE | 831.23M |
| Genfit | 433.47M |
| Cellectis | 243.74M |
| Transgene | 213.59M |
| Sensorion | 210.24M |